China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 China Medical System Holdings Ltd. Feb 14, 2025 21:00 JST Read More
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 China Medical System Holdings Ltd. Feb 14, 2025 20:00 HKT/SGT Read More
Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease Eisai Feb 14, 2025 11:09 HKT/SGT Read More
CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024 CGFNS International Feb 12, 2025 08:00 HKT/SGT Read More
An Incredible KLAS Triple-Award Win for AGFA HealthCare! Agfa HealthCare Feb 10, 2025 22:00 HKT/SGT Read More
Olympus Recognized on CDP's "A List", the Highest Rating in the Field of Climate Change Olympus Feb 10, 2025 10:00 HKT/SGT Read More
Mallia Therapeutics 與 Northway Biotech 宣布合作生產可溶性 CD83 蛋白 用於脫髮治療 Northway Biotech Feb 05, 2025 08:00 HKT/SGT Read More
Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment Northway Biotech Feb 04, 2025 18:00 HKT/SGT Read More
Eisai to Provide Guidance on Reducing the Risk of Cognitive Decline and Nutrition, and Development Guidelines for Home Delivery Meals/Meal Kits to Food-Related Companies Eisai Feb 03, 2025 16:23 HKT/SGT Read More
国立長寿医療研究センターとエーザイ、認知機能低下リスクの低減と栄養に関するガイダンス、および 宅配食/ミールキット開発の手引きを作成し、食品関連企業へ提供開始 Eisai Feb 03, 2025 10:40 JST Read More
TANAKA PRECIOUS METAL TECHNOLOGIES Launches Visi Fine(R): A Group of Precious Metal Materials for Medical Device Components TANAKA PRECIOUS METAL GROUP Co., Ltd. Jan 31, 2025 10:00 HKT/SGT Read More
FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Eisai Jan 28, 2025 08:46 HKT/SGT Read More
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 China Medical System Holdings Ltd. Jan 24, 2025 23:00 JST Read More
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 China Medical System Holdings Ltd. Jan 24, 2025 23:00 HKT/SGT Read More
Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company Eisai Jan 22, 2025 16:18 HKT/SGT Read More